Zhongzhi Pharmaceutical Holdings Limited ( (HK:3737) ) has issued an announcement.
Zhongzhi Pharmaceutical Holdings Limited has revised the terms of reference for its Nomination Committee, which was initially adopted in 2015. The updated guidelines emphasize the inclusion of diverse gender representation and require a majority of independent non-executive directors in the committee. This move is likely to enhance the company’s governance structure by promoting diversity and independence in its board nominations, potentially impacting its operational transparency and stakeholder confidence.
More about Zhongzhi Pharmaceutical Holdings Limited
YTD Price Performance: -8.08%
Average Trading Volume: 292,403
Technical Sentiment Signal: Buy
Current Market Cap: HK$770.8M
For a thorough assessment of 3737 stock, go to TipRanks’ Stock Analysis page.